We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. As Healio previously reported, more than 90% of ...
Socioeconomic disparities in access to and outcomes of liver transplantation (LT) for hepatocellular carcinoma (HCC). A phase 2 dose expansion study of ZG006, a trispecific T cell engager targeting ...
Clinical Benefit and Expedited Approval of Cancer Drugs in the United States, European Union, Switzerland, Japan, Canada, and Australia Randomized, single-blinded study. Patients with NETs received ...
Credit: Getty Images. The NETTER-2 trial included patients with newly diagnosed SSTR-positive, Grade 2 and 3, advanced gastroenteropancreatic neuroendocrine tumors. First-line treatment with lutetium ...
October 12, 2012 (Montreal, Quebec) — In a finding described as both surprising and practice-changing, octreotide (Sandostatin, Novartis) showed no benefit over less expensive, more accessible ...
The prescribed dosage for Sandostatin (octreotide acetate) may depend on a person’s individual treatment plan. Factors such as your medical history may affect your dosage of Sandostatin. Sandostatin ...
As with other drugs, Sandostatin (octreotide acetate) can cause side effects, such as gallbladder problems and fatigue. If you’re not able to tolerate the side effects of Sandostatin, talk with your ...
(RTTNews) - Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries (TEVA), announced the launch of the first and only generic version of Sandostatin LAR Depot, in the United States.
Syringe and Vials To date, the Company has not received any reports of adverse reactions related to this recall. Mylan Institutional LLC, a Viatris Company, has voluntarily recalled 1 lot of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results